Introduction {#s1}
============

Long arrays of tandemly repeated short DNA sequences (known as satellites) are abundant in centromeres ([@bib38]) and pericentromeric regions ([@bib11]), and contribute to chromosome segregation and other heterochromatin functions ([@bib6]; [@bib9]). Surprisingly, satellite DNAs are expressed in many multicellular eukaryotes, and their aberrant transcription may contribute to carcinogenesis and cellular toxicity ([@bib43]; [@bib14]; [@bib45]). Satellite transcription and/or RNAs may also promote centromere and heterochromatin functions ([@bib26]; [@bib17]; [@bib39]; [@bib34]; [@bib33]).

In *D. melanogaster*, simple, tandemly repeated satellite DNAs, such as AAGAG(n) and AATAT(n), comprise \~15--20% of the genome ([@bib23]; [@bib12]). Given the emerging roles of non-protein coding RNAs (ncRNAs) in chromatin organization and other biological functions ([@bib32]), we investigated whether heterochromatic satellite transcripts are required for normal viability and development.

Results {#s2}
=======

We first analyzed RNA expression for 31 of the most abundant satellite DNAs, using published RNA-seq data (modENCODE) ([@bib2]) and RNA-Fluorescence In-Situ Hybridization (RNA-FISH) ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Further characterizations and functional analyses were focused on AAGAG(n) RNA (hereafter AAGAG RNA) because it is highly abundant, and a previous study suggested it was linked to the nuclear matrix and necessary for viability ([@bib29]). Northern blot analysis of RNA isolated from stage 1--4 embryos shows that AAGAG RNA is maternally loaded as an \~1500 nucleotide (nt) transcript. Smaller RNAs (\~20--750 nt) accumulate in later stage embryos (2--24 hr) and third instar larvae (L3 larvae) ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). AAGAG RNA-FISH in 0--18 hr embryos and L3 larvae revealed localization to only one or a few nuclear foci, with no visible cytoplasmic signal ([Figure 1](#fig1){ref-type="fig"}, A and D). AAGAG RNA foci are not detected prior to embryonic cycle 11, but by cycles 12 and 13, 33% and 67% of embryos (respectively) have one or more foci ([Figure 1---figure supplement 2, B and C](#fig1s2){ref-type="fig"}). Furthermore, 100% of embryos exhibit nuclear AAGAG RNA foci by blastoderm (cycle 14,\~2 hr after egg laying), coincident with the formation of stable, mature heterochromatin ([@bib37]; [@bib44]) ([Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). Surprisingly, the complementary RNA (CUCUU(n)) is not observed in Northern or RNA-FISH analysis ([Figure 1---figure supplement 4, B](#fig1s4){ref-type="fig"} and data not shown, respectively), suggesting that most or all of the stable embryo RNA expressed from tandem AAGAG(n) DNA present at multiple genome locations corresponds to AAGAG(n) and not CUCUU(n). This conclusion is supported by the results of RNase digestion experiments, which demonstrate that cycle 14 AAGAG RNA foci contain single-stranded RNA (ssRNA), and not R-loops or double-stranded RNA (dsRNA) ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). A combination of transcriptome mining, Northern blotting and RNA-FISH indicates that the majority of AAGAG RNA is transcribed from loci in 2R, X and 3R heterochromatin ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Finally, we ruled out the possibility that detected foci represent DNA, since signal was abolished by RNaseIII, but not RNaseH treatments after probe hybridization ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}).

![AAGAG(n) RNA localizations in embryos and larvae.\
(**a**) AAGAG RNA distributions (magenta) throughout embryonic and larval development in Oregon R flies. DNA/DAPI = blue; all images are confocal sections. White box indicates location of enlarged nucleus (right column). (**b**) Distributions of AAGAG RNA in intact larval L3 brain (left) and salivary gland (SG) tissue (right) (confocal sections). (**c**) Salivary gland squash projection indicating presence of AAGAG RNA (magenta, see arrows) at the chromocenter (marked with H3K9me2), and not the euchromatic arms. (**d**) Brain cell sections show that there are one or two AAGAG RNA foci per nucleus that are located in or near the pericentromeric heterochromatin (H3K9me2 antibody IF, green). Specifically, 100% of nuclei (N = 5) with AAGAG foci contain foci that completely or partially co-localize with H3K9me2 (left panel). Of these nuclei, (20%) have an additional AAGAG focus that generally does not co-localize with H3K9me2. (**e**) Projections of representative nuclei probed for AAGAG RNA (magenta) and AAGAG DNA (yellow) and stained for H3K9me3 (gray) and DNA (DAPI = blue). Left = cycle 12 nuclei prior to stable heterochromatin formation; right = early cycle 14 nucleus during heterochromatin formation. Note that in cycle 12, the few AAGAG RNA foci do not co-localize with AAGAG DNA. In cycle 14, AAGAG RNA foci co-localize with AAGAG DNA and H3K9me3.](elife-48940-fig1){#fig1}

To determine where these transcripts localize within the nucleus, we simultaneously performed antibody staining (IF) for a histone post-translational modification enriched in heterochromatin (H3K9me3), and FISH for both AAGAG RNA and DNA. In cycle 12 embryos, AAGAG RNA is distributed randomly throughout the nucleus ([Figure 1E](#fig1){ref-type="fig"}) and does not co-localize with AAGAG(n) DNA. Once stable heterochromatin forms (cycle 14) ([@bib44]), AAGAG RNA foci specifically co-localize with H3K9me3 ([Figure 1E](#fig1){ref-type="fig"}). By stage 13 embryos (\~9.5 hr after egg-laying) AAGAG RNA is specifically enriched in the ventral ganglia (neural tissue), and foci remain either co-localized with or immediately adjacent to heterochromatin ([Figure 1B and D](#fig1){ref-type="fig"}). In addition, AAGAG RNA localizes to the chromocenter in polytene larval salivary glands ([Figure 1C](#fig1){ref-type="fig"}).

The presence of AAGAG RNA throughout development suggested a potential role in development or viability. This hypothesis was tested by depleting AAGAG RNA in somatic cells, using actin-GAL4-driven AAGAG shRNA expression ([Figure 1---figure supplement 6](#fig1s6){ref-type="fig"}). Depletion of AAGAG RNA results in significantly lower viability by pupal stage compared to controls, with most lethality occurring during third instar larval (L3) stages ([Figure 1---figure supplement 6, G and H](#fig1s6){ref-type="fig"}, respectively). We conclude that AAGAG RNA associates with the earliest forms of heterochromatin, maintains this localization at least partially throughout embryonic and larval development, is enriched in neural tissue, and is important for viability.

Surviving act-GAL4-driven AAGAG RNAi adults exhibited partial sterility, prompting further investigation into the distribution and potential functions of AAGAG RNA in the germ line (see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} for an overview of spermatogenesis). In larval and adult testes, high levels of AAGAG RNA are observed in primary spermatocytes, where they are enriched in regions adjacent to the DAPI-bright 'chromosome territories' located at the nuclear periphery ([Figure 2](#fig2){ref-type="fig"}, A to C). This pattern is distinct from CUCUU(n) RNA, which is localized to the lumen in primary spermatocytes ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). AAGAG RNA is not detectable, even with amplified signal, at earlier stages near the hub, or at later stages (meiosis I and II, and subsequent stages of sperm development). Spermatocyte AAGAG RNA originates from the same 2R, 3R and X heterochromatic satellite regions identified in somatic cells and is specifically not generated from the Y chromosome ([Figure 2---figure supplement 2A and B](#fig2s2){ref-type="fig"}, respectively).

![AAGAG RNA is enriched in primary spermatocytes and necessary for male fertility.\
(**a**) Confocal section of a larval testis. RNA-FISH to AAGAG = magenta, H2Av (chromatin) IF = gray, DNA (DAPI) = blue. S3, S5, and S6 refer to primary spermatocyte stages. (**b**) Enlarged confocal sections (representative boxes in a) of spermatocyte stages in larvae testes; scale bars = 5 µm. (**c**) Schematic summary of AAGAG RNA (magenta) localization in adult testes (see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} for a detailed description of spermatogenesis stages and events). AAGAG RNAs are visible in 16 cell primary spermatocytes (dark pink), and potentially 16 cell spermatogonial cysts (light pink); no AAGAG RNA was detected at earlier stages (hub, 2--8 cell spermatogonial cysts) or after the primary spermatocyte stage (meiosis I and II, sperm elongation- which includes leaf, canoe, individualization steps, and maturation). Post-round spermatid stages are indicated as spermatid nuclei. (**d**) Fertility after depletion of AAGAG(n) RNA in male primary spermatocytes or female ovaries using the Bam-GAL4 driver. An \~72% reduction in AAGAG RNA levels in testes (see [Figure 2---figure supplement 3, B and C](#fig2s3){ref-type="fig"}) results in complete male sterility but has no effect on female fertility. Expression of AAGAG(37) RNA simultaneously with AAGAG RNAi (both driven by Bam-Gal4) partially rescues male sterility (46% fertile). Expression of AAGAG RNA alone, without depletion of endogenous AAGAG RNAs, has no impact on male fertility. Statistically significant differences based on T-tests (two tailed, type three) are indicated by horizontal lines; \*\*\*p\<0.001, \*\*p\<0.01; variation is represented by stdev.](elife-48940-fig2){#fig2}

To deplete AAGAG RNA in 4--16 cell spermatogonial cysts, we used the Bag of marbles (Bam)-GAL4 ([@bib42]) driver to express AAGAG shRNA. Strikingly, AAGAG depletion (\~72% reduction) results in 100% male sterility, with no impact on female fertility ([Figure 2D](#fig2){ref-type="fig"}). AAGAG RNAi using drivers expressed earlier in spermatogenesis does not cause fertility defects ([Table 1](#table1){ref-type="table"}). We conclude that expression of AAGAG RNA in primary spermatocytes is required for male fertility.

###### Male fertility in AAGAG RNAi with GAL4 drivers expressed at earlier testes stages than Bam.

  -------------------------------------------------------------------------------------------------------------------------
  GAL4 RNAi driver   Expression location\                      \% fertile   + /- stdev.   Minimum number of males per set
                     ([@bib5])                                                            
  ------------------ ----------------------------------------- ------------ ------------- ---------------------------------
  Fascillin          Hub                                       94           16            15

  PTC                Soma- CySCs and cyst cells                90           5             18

  Traffic Jam        Soma- Hub and CySCs                       97           4             12

  Dpp1               Soma- CySCs and early cyst cells          96           6             17

  Nanos              Germline- GSCs and early germline cysts   83           5             13
  -------------------------------------------------------------------------------------------------------------------------

These results suggested that male infertility upon AAGAG RNA depletion would be caused by defects at stages where AAGAG RNA is expressed. Surprisingly, Bam-GAL4-driven depletion of AAGAG RNA resulted in no gross morphological defects prior to or during meiosis I or II in pupal or adult (0--6 hr and 4--7 days post-eclosion) testes. However, individualized mature sperm DNA was completely absent from the seminal vesicles (SV), in contrast to their abundance in controls ([Figure 3A](#fig3){ref-type="fig"}), demonstrating that AAGAG RNA is important for later steps in spermatogenesis. In fact, the first visible defects are observed during the canoe, individualization and maturation stages ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"} and [Figure 3B](#fig3){ref-type="fig"}), which are devoid of detectable AAGAG RNA in wild-type testes ([Figure 2C](#fig2){ref-type="fig"}). For instance, aberrant canoe stage and individualizing sperm DNA (i.e. irregular, long and decondensed sperm DNA) were observed at significantly higher frequencies after AAGAG RNA depletion, compared to scrambled RNAi controls ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} and [Figure 3E](#fig3){ref-type="fig"}). At later individualization stages, sperm bundles in AAGAG RNA depleted testes often contained less than the normal 64 sperm and were disorganized, displaying 'lagging' sperm nuclei and loosely packed sperm bundles ([Figure 3, B and E](#fig3){ref-type="fig"}). Finally, sperm DNA present was abnormally 'kinked,' 'needle eyed' or 'knotted' in appearance, and normal, mature forms of sperm DNA readily found in basal regions (just prior to entry into the seminal vesicle) of control testes were never observed after AAGAG depletion ([Figure 3B](#fig3){ref-type="fig"}). These phenotypes indicated that AAGAG RNA is important for sperm nuclear organization, similar to the consequences of defective histone-protamine transitions observed previously ([@bib30]; [@bib16]). Strikingly, antibody IF revealed that Bam-GAL4-driven AAGAG RNA depletion caused reduced and defective incorporation of the transition protein Mst77F ([Figure 3C](#fig3){ref-type="fig"}), an absence of Protamine A/B ([Figure 3D](#fig3){ref-type="fig"}), and histone retention into the late canoe stage ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

![AAGAG RNAi depletion in mitotic germline cysts and spermatocytes (Bam-GAL4 driver) results in severe defects in sperm maturation and protamine deposition.\
(**a**) Seminal vesicles (SVs) in testes from 0 to 6 hr old adults; DAPI (DNA) = cyan. Mature sperm nuclei visible as thin, elongated DAPI signals in the scrambled control (top, white arrow) are absent after AAGAG RNAi. Individualized mature sperm (white arrow) are visible in SVs from AAGAG RNAi males that also express AAGAG(37) RNA (partial rescue, 4--7 day old adults). (**b**) Bundles of elongating sperm nuclei visible in the scrambled RNAi control (top). Defective 'decondensed' (middle, white arrowheads), 'knotted,' 'kinked 'needle eyed' and 'lagging' (bottom, white arrowheads) sperm phenotypes are visible in the AAGAG RNAi but are much less frequent or absent in controls (see e). (**c**) Transition Protein Mst77F (red) is present on sperm DNA in control RNAi but is largely absent and/or disorganized after AAGAG RNAi (dashed boxes indicate regions in the zoomed images to the right). (**d**) Protamine A/B (purple) is present on sperm DNA in the scrambled control RNAi but is absent after AAGAG RNAi. Scale bars = 10 µm except for zoomed images in c and d = 8 µm. (**e**) Quantitation of sperm defects (4--6 day adult testes) associated with AAGAG RNAi depletion, along with AAGAG RNA rescue, compared to scrambled RNAi control.](elife-48940-fig3){#fig3}

Importantly, fertility defects resulting from AAGAG RNA depletion are partially rescued by simultaneously expressing AAGAG RNA (185 bases, 37 repeats), when both are controlled by the Bam-GAL4 driver. Under these conditions we observe a 2-fold increase in AAGAG RNA signal compared to AAGAG RNAi alone ([Figure 2---figure supplement 3D](#fig2s3){ref-type="fig"}), which is sufficient to partially restore male fertility (46% with AAGAG RNA expression compared to 0% in AAGAG RNAi alone, [Figure 2D](#fig2){ref-type="fig"}), the presence of mature sperm in the seminal vesicles ([Figure 3A](#fig3){ref-type="fig"}), and normal sperm DNA morphology ([Figure 3E](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). We conclude that RNA transcribed from the simple tandem repeat AAGAG(n) in primary spermatocytes is necessary for completing spermatogenesis and male fertility in *Drosophila melanogaster,* at least in part by promoting the histone-protamine transition and/or other post-meiotic steps in sperm maturation.

Discussion {#s3}
==========

Here, we demonstrate that AAGAG(n) satellite RNAs are transcribed from heterochromatic regions on multiple chromosomes, cluster into nuclear foci, associate with the earliest forms of heterochromatin in embryos, and persist throughout fly development. AAGAG RNA is important for viability, though further investigations are necessary to determine its functions in early development. Most strikingly, we observe that AAGAG RNA is expressed in the male germ-line and is absolutely essential for male fertility.

It is surprising that AAGAG RNA is expressed only in primary spermatocytes yet is critical for completing much later stages of sperm development, when AAGAG RNA is not detected. Specifically, defects in late spermatogenesis, including canoe, individualization and maturation stages and the histone-protamine exchange, were observed when AAGAG RNA was depleted in primary spermatocytes, and expression of AAGAG RNA at the same stage partially restored these fertility and sperm defects. It is interesting that aberrant histone-protamine transition and sperm individualization are also observed in Segregation Distorter (SD) testes, where the affected sperm contain abnormally high numbers of another satellite repeat (Responder, or Rsp) ([@bib21]). We suggest that AAGAG RNA, and perhaps other satellite RNAs (e.g. Rsp), function in primary spermatocytes to 'prime' cells and/or chromosomes to successfully accomplish downstream, post-meiotic sperm development.

Although the molecular mechanisms directly impacted by AAGAG RNA are currently unknown, the spatial and temporal disconnect between its expression and depletion phenotypes limit the possibilities. We speculate that proper histone:protamine exchange and post-meiotic chromatin organization require AAGAG RNA in primary spermatocytes to sequester or exclude factors that regulate localization of late-acting proteins or ncRNAs ([Figure 4A](#fig4){ref-type="fig"}), form essential complexes or alter post-translational modifications ([Figure 4B](#fig4){ref-type="fig"}), or regulate global genome organization ([Figure 4C](#fig4){ref-type="fig"}), such as condensation or chromosome 'bundling' ([@bib13]), which could impact expression of genes critical for later spermatogenesis events. It is also possible that AAGAG RNA directs the proper chromatin organization of the cognate satellite DNAs ([Figure 4D](#fig4){ref-type="fig"}), as demonstrated for small RNA-directed, homology-based recruitment of histone modifying proteins to heterochromatin ([@bib1]).

![Model for AAGAG RNA function during spermatogenesis.\
AAGAG RNA (magenta) present only in primary spermatocytes (light blue = chromosome territories) acts directly or indirectly to promote important processes later in sperm maturation, including the histone-protamine transition and individualization. AAGAG RNA could ensure normal completion of later events by mediating: (**a**) proper localization of factors (RNA and/or protein) through sequestration (green) or exclusion (orange), (**b**) formation of molecular complexes or modifications (e.g. PTMs) (green blobs plus blue ovals), (**c**) regulation of global DNA/chromatin organization (e.g. condensation, Y loops, Higher Order Structures (HOS)) which for example could impact expression of critical spermatogenesis genes, or (**d**) local DNA/chromatin organization of cognate AAGAG loci, as observed for heterochromatin recruitment by siRNAs. Although direct experiments are required to test these models, we favor d) because it can accommodate both fast turnover of satellite sequences during evolution and sequence-independent roles in ensuring fertility (see text).](elife-48940-fig4){#fig4}

It is also worth noting that the expression of simple repeats for essential functions seems incompatible with the fast evolution of satellite DNAs, reflected in dramatic changes in both sequences and copy numbers across species ([@bib40]). Specifically, AAGAG is one of the most abundant simple repeats in *D. melanogaster*, comprising \~5% of the genome ([@bib24]). However, the amount of AAGAG is several orders of magnitude lower in the closely related *D. simulans* and *D. sechellia*, and is nearly absent in other *Drosophila* species ([@bib40]). It is possible that in species with few or no AAGAG repeats, low levels of AAGAG RNA are sufficient for fertility, but we favor the hypothesis that expression of different lineage-specific satellite arrays are required for normal sperm maturation. In this context, it is interesting that new lineage-specific protein-coding genes ([@bib4]) are biased toward testis-expression and acquisition of essential functions in male reproduction, including spermatogenesis ([@bib7]). Selective pressures proposed to drive the fast evolution of new testis-expressed genes could also impact satellite RNA evolution and function, such as sperm competition, sexual conflict, or antagonistic interactions with germline parasites and/or selfish DNAs ([@bib18]) . However, it is unclear how completely different satellite RNA sequences would retain functions such as promoting formation or proper localization of regulatory complexes required for later spermatogenesis events ([Figure 4A--C](#fig4){ref-type="fig"}). Thus, we posit that a requirement for satellite RNA-mediated packaging of cognate satellite DNAs ([Figure 4D](#fig4){ref-type="fig"}) provides the most parsimonious explanation for both the fast turnover and its roles in ensuring fertility. This model is attractive because transcription of any new or even evolving satellites would avoid deleterious dis-organization of the corresponding DNAs, independent of RNA primary sequences or secondary structures. Detailed analyses of the functions of distinct satellite RNAs in *D. melanogaster* and other Drosophilds are required to test the mechanistic hypotheses outlined in [Figure 4](#fig4){ref-type="fig"}. Regardless, our results provide a strong impetus for additional studies of satellite RNA functions, which could elucidate new roles of so-called 'junk DNA' in health, disease and evolution.

Materials and methods {#s4}
=====================

Imaging {#s4-1}
-------

Most images were acquired using a Zeiss LSM710 confocal microscope using 40X water or 63X oil objectives. For these confocal images, projections were acquired as z-stacks with step sizes depending on the sample. Image files were then processed and analyzed using Fiji. Non-rescue testes images in [Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} were acquired using DeltaVision Elite wide-field microscope system (Applied Precision). Images were acquired as z-stacks with a step size of 0.5 μm, raw data files were deconvolved using a maximum intensity algorithm. 3D z-stack images were represented in 2D by projection using SoftWorx (Applied Precision).

RNA probe generation for RNA-FISH {#s4-2}
---------------------------------

RNA probes were made by using oligo templates with antisense T3 promoters on the 3'ends, hybridizing an oligo composed of sense T3 promoter so as to create a double stranded 3' end, or in the case of 359 bp repeat, amplification with oligos containing T3 and T7 promoter ends on genomic DNA using standard protocols. Probe templates were then transcribed with T3 RNA polymerase (or T7 for one strand of 359 bp repeat) and either UTP-biotin or UTP-digoxigenin labels, or in the case of RNA without Uracil, biotin-ATP. Oligos are listed in [Table 2](#table2){ref-type="table"} and were ordered standard desalted from IDT. Reaction conditions were as follows: In a 40 ul reaction, 1X RNApol reaction buffer (NEB cat. MO3782), 1 mM each final concentration of ATP, GTP, CTP and 0.62 mM UTP, supplemented with 0.35 mM final concentration of either digoxegenin-11-UTP (Roche cat. 3359247910), biotin-UTP (Sigma, cat. 11388908910), or biotin-11-ATP (Perkin Elmer, cat. NEL544001EA), 1 Unit Protector RNase inhibitor (Roche cat. 3335402001), 5 μM each of probe template and T3 promoter oligo (5'-AATTAACCCTCACTAAAG), and H~2~0 to 40 μl were combined. Reactions were heated to 80°C, 3 min to denature probes, iced 2 min., 4 μl (or 200Units) of T3 (or T7) RNA polymerase (NEB cat. M0378S) added and incubated at 37°C overnight. 2 μl Turbo DNAse (ThermoFisher Cat. AM2238) was then added to degrade DNA templates, incubated at 37°C for 15 min and the reaction stopped by adding 1.6 μl of 500 mM EDTA. Probes were then purified using standard sodium acetate/ethanol purification. Probe concentration was then assessed using Qubit RNA high sensitivity protocols and reagents and stored at −80°C.

###### Oligos for RNA probes.

  ----------------------------------------------------------------------------------------------------------------------------------------
  Repeat or region                         Oligo with T3 antisense promoter
  ---------------------------------------- -----------------------------------------------------------------------------------------------
  CAGC(n)                                  CAGCCAGCCAGCCAGCCAGCCAGCTCTCCCTTTAGTGAGGGTTAATT

  CCCA(n)                                  CCCACCCACCCACCCACCCACCCACCCATCTCCCTTTAGTGAGGGTTAATT

  CATTA(n)                                 CATTACATTACATTACATTACATTATCTCCCTTTAGTGAGGGTTAATT

  CGGAG(n)                                 CGGAGCGGAGCGGAGCGGAGCGGAGTCTCCCTTTAGTGAGGGTTAATT

  CGA(n)                                   CGACGACGACGACGACGACGACGATCTCCCTTTAGTGAGGGTTAATT

  CAACT(n)                                 CAACTCAACTCAACTCAACTCAACTTCTCCCTTTAGTGAGGGTTAATT

  CGAAG(n)                                 CGAAGCGAAGCGAAGCGAAGCGAAGTCTCCCTTTAGTGAGGGTTAATT

  CCCCAG(n)                                CCCCAGCCCCAGCCCCAGCCCCAGTCTCCCTTTAGTGAGGGTTAATT

  CCGAG(n)                                 CCGAGCCGAGCCGAGCCGAGCCGAGTCTCCCTTTAGTGAGGGTTAATT

  CGGAA(n)                                 CGGAACGGAACGGAACGGAACGGAATCTCCCTTTAGTGAGGGTTAATT

  CACCC(n)                                 CACCCCACCCCACCCCACCCCACCCTCTCCCTTTAGTGAGGGTTAATT

  CTAGT(n)                                 CTAGTCTAGTCTAGTCTAGTCTAGTTCTCCCTTTAGTGAGGGTTAATT

  CATCG(n)                                 CATCGCATCGCATCGCATCGCATCGTCTCCCTTTAGTGAGGGTTAATT

  CAT(n)                                   CATCATCATCATCATCATCATCATTCTCCCTTTAGTGAGGGTTAATT

  CAAAC(n)                                 CAAACCAAACCAAACCAAACCAAACTCTCCCTTTAGTGAGGGTTAATT

  CGAAA(n)                                 CGAAACGAAACGAAACGAAACGAAATCTCCCTTTAGTGAGGGTTAATT

  CATAT(n)                                 CATATCATATCATATCATATCATATTCTCCCTTTAGTGAGGGTTAATT

  GAAA(n)                                  GAAAGAAAGAAAGAAAGAAAGAAATCTCCCTTTAGTGAGGGTTAATT

  CAGAA(n)                                 CAGAACAGAACAGAACAGAACAGAATCTCCCTTTAGTGAGGGTTAATT

  AAGGAG(n)                                AAGGAGAAGGAGAAGGAGAAGGAGAAGGAGTCTCCCTTTAGTGAGGGTTAATT

  AAGAGG(n)                                AAGAGGAAGAGGAAGAGGAAGAGGAAGAGGTCTCCCTTTAGTGAGGGTTAATT

  AATAC(n)                                 AATACAATACAATACAATACAATACAATACTCTCCCTTTAGTGAGGGTTAATT

  AATAG(n)                                 AATAGAATAGAATAGAATAGAATAGAATAGTCTCCCTTTAGTGAGGGTTAATT

  AATAGAC(n)                               AATAGACAATAGACAATAGACAATAGACTCTCCCTTTAGTGAGGGTTAATT

  AATAACATAG(n)                            AATAACATAGAATAACATAGAATAACATAGTCTCCCTTTAGTGAGGGTTAATT

  AACAC(n)                                 AACACAACACAACACAACACAACACAACACTCTCCCTTTAGTGAGGGTTAATT

  dodeca(n)                                ACCGAGTACGGGACCGAGTACGGGTCTCCCTTTAGTGAGGGTTAATT

  GTGTT(n)                                 GTGTTGTGTTGTGTTGTGTTGTGTTGTGTTTCTCCCTTTAGTGAGGGTTAATT

  GTAAT(n)                                 GTAATGTAATGTAATGTAATGTAATGTAATTCTCCCTTTAGTGAGGGTTAATT

  GTATT(n)                                 GTATTGTATTGTATTGTATTGTATTGTATTTCTCCCTTTAGTGAGGGTTAATT

  TTAA (n)                                 TTAATTAATTAATTAATTAATTAATTAATTAATCTCCCTTTAGTGAGGGTTAATT

  CAAT (n)                                 CAATCAATCAATCAATCAATCAATCAATCAATTCTCCCTTTAGTGAGGGTTAATT

  AAGAG(n)                                 GAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAATCTCCCTTTAGTGAGGGTTAATT

  CTCTT(n)                                 CTCTTCTCTTCTCTTCTCTTCTCTTCTCTTTCTCCCTTTAGTGAGGGTTAATT

  359 Forward                              AATTAACCCTCACTAAAGGGAGAAATGGAAATTAAATTTTTTGG

  359 Reverse                              TTAATACGACTCACTATAGGGAGAGTTTTGAGCAGCTAATTACC

  chr2R:1,825,641--1825699 sense           GGCAGTTTATGTGCGTACAACAACAACAGGACTGCAAACAAAACACGAAACAGATATTTTTCTCCCTTTAGTGAGGGTTAATT

  chr2R:1,825,641--1825699 anti-sense      AAAATATCTGTTTCGTGTTTTGTTTGCAGTCCTGTTGTTGTTGTACGCACATAAACTGCCTCTCCCTTTAGTGAGGGTTAATT

  chr2R:1,826,691--1,826,740 sense         TAGACACATCTACGAAGACACAATTCTACAAGAACTAAACAACAAAAAGTTCTCCCTTTAGTGAGGGTTAATT

  chr2R:1,826,691--1,826,740 anti-sense    ACTTTTTGTTGTTTAGTTCTTGTAGAATTGTGTCTTCGTAGATGTGTCTATCTCCCTTTAGTGAGGGTTAATT

  chrX:11,830,844--11,830,910 sense        CCAAGCTTCAGGAGAAAGAGAAAGAAGAAAGCTTTAAACTTAAGGAAAGAGAAGAGAGCCTTAGGATTCTCCCTTTAGTGAGGGTTAATT

  chrX:11,830,844--11,830,910 antisense    CTAAGGCTCTCTTCTCTTTCCTTAAGTTTAAAGCTTTCTTCTTTCTCTTTCTCCTGAAGCTTGGCTTTCTCCCTTTAGTGAGGGTTAATT

  chrX:12,660,096--12,660,145 sense        TCGCACACACACACGCAACACTTAGGCACACATAGGAGATAGAGTGAGATCTCCCTTTAGTGAGGGTTAATT

  chrX:12,660,096--12,660,145 anti-sense   TCTCACTCTATCTCCTATGTGTGCCTAAGTGTTGCGTGTGTGTGTGCGATCTCCCTTTAGTGAGGGTTAA TT

  chrX:22,453,019--22,453,076 sense        CGACAGACAGTAAAATTAAACAAACTGCGGACGCGTGTGACAGAACTAATCCAACTTTCTCCCTTTAGTGAGGGTTAATT

  chrX:22,453,019--22,453,076 anti-sense   AAGTTGGATTAGTTCTGTCACACGCGTCCGCAGTTTGTTTAATTTTACTGTCTGTCGTCTCCCTTTAGTGAGGGTTAATT

  chr3R:3,169,758--3,169,820 antisense     TCGGAAGAGACTAAACTTGTGCATTCGATATAGCTCTTTGTCGGCCCTAGCTGCTGTAAACAATCTCCCTTTAGTGAGGGTTAATT

  chr3R:3,169,758--3,169,820 sense         TTGTTTACAGCAGCTAGGGCCGACAAAGAGCTATATCGAATGCACAAGTTTAGTCTCTTCCGATCTCCCTTTAGTGAGGGTTAATT

  chr3R:3,170,372--3,170,441 antisense     TTAAACTATATTAAACATTGTATATAAGTATAATAGCGAATACTATTTACGTATATGTTCT\
                                           TTCATAAATTCTCCCTTTAGTGAGGGTTAATT

  chr3R:3,170,372--3,170,441 sense         ATTTATGAAAGAACATATACGTAAATAGTATTCGCTATTATACTTATATACAATGTTTAATATAGTTTAATCTCCCTTTAGTGAGGGTTAATT
  ----------------------------------------------------------------------------------------------------------------------------------------

RNA-FISH buffers {#s4-3}
----------------

1.  PBT solution: 1X PBS and 0.1% Tween-20.

2.  Western Blocking Reagent 10X: 10% casein in 100 mM maleic acid; 150 mM NaCl; pH 7.5. heated at 60°C for 1 hr to dissolve.

3.  PBT block: 1:1 PBT/2X WBR;

4.  Hybridization buffer: 50% formamide, 5X SSC, 100 μg/mL heparin, 100 μg/mL sonicated salmon sperm DNA, and 0.1% Tween-20, filtered through a 0.2 μm filter.

For clarity, the methods for RNA-FISH probe hybridization and detection are numbered below.

### RNA-FISH methods {#s4-3-1}

#### Protocol 1. RNA-FISH probe hybridization and primary antibody incubation {#s4-3-1-1}

RNA probe hybridization for all tissues was carried about according to [@bib22], steps 10--17 under subheading \#3. Samples were then washed one time with PBT then blocked in PBT block 1 hr at room temperature. Samples were then processed for either 'non-Tyramide Signal Amplification (TSA) probe amplification' (Protocol 2) or 'TSA amplification for RNA-FISH probe detection' (Protocol 3).

#### Protocol 2. Non-TSA probe detection for RNA-FISH {#s4-3-1-2}

For 'non-TSA amplification', samples were incubated with either mouse anti-digoxigenin-Cy5 (source unknown) or rabbit anti-digoxigenin A488 (Invitrogen cat\# 700772) in PBT block at 1/200 dilution for 1 hr at room temperature. Afterwards, samples were incubated 6x's 10 min each in PBT block, stained with DAPI 10 min, washed 3'xs 10 min. each in PBS and mounted in Prolong-Gold antifade mountant (Thermofisher, cat. P36390).

#### Figures processed using this protocol {#s4-3-1-3}

[Figure 1D](#fig1){ref-type="fig"} (see below for 1C); [Figure 2A and B](#fig2){ref-type="fig"}; [Figure 1---figure supplement 4, C--H](#fig1s4){ref-type="fig"} for AAGAG only; [Figure 1---figure supplement 6, A--C](#fig1s6){ref-type="fig"}; [Figure 2---figure supplements 2](#fig2s2){ref-type="fig"} and [3](#fig2s3){ref-type="fig"}.

#### Protocol 3. TSA amplification for RNA-FISH probe detection {#s4-3-1-4}

For samples undergoing 'TSA amplification for RNA-FISH probe detection,' samples were incubated with primary antibody (1/400 dilution of mouse anti-digoxigenin coupled to biotin (Jackson Immuno Research cat.200-062-156, lot. 123482)), with 0.2 U/μl protector RNAse inhibitor and incubated overnight at 4°C. Next, samples were washed 6x's 10 min each in PBT block. The next steps are essentially as per 'tyramide signal amplification kit' protocols (ThermoFisher) but with reagents purchased separately: Samples were incubated with 1:100 streptavidin-HRP (Molecular probes, cat. S911) in PBT block for 1 hr at room temperature. Samples were then washed in 1:1 PBT/2XWBR 6x's 10 min each, once with PBT, and 2x's with PBS. Samples were then incubated with Alexa 647 tyramide (TSA Reagent, Alexa Fluor 647 Tyramide cat. T20951) according to company protocols. Essentially, this consisted of adding 1 μl of 30% hydrogen peroxide to 200 μl tyramide signal kit amplification buffer, then diluting this solution 1/100 in tyramide signal amplification buffer for a final hydrogen peroxide concentration of 0.0015%. This solution was then added to the sample and incubated at room temperature for 1 hr in the dark. Samples were then washed 1x with PBS for 10 min, stained with DAPI for 10 min, washed 4x's with PBS 10 min. each, and mounted in Prolong Gold Antifade mountant.

#### Figures processed using this protocol {#s4-3-1-5}

[Figure 1A and B](#fig1){ref-type="fig"} (see below for 1E); [Figure 1---figure supplements 1](#fig1s1){ref-type="fig"}--[3](#fig1s3){ref-type="fig"}; [Figure 1---figure supplement 4, C--H](#fig1s4){ref-type="fig"} for non AAGAG RNA detection (ie 2R and X heterochromatic transcripts); [Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}.

RNA-FISH of repeats in embryos {#s4-4}
------------------------------

For RNA-FISH of repeat RNAs, 0--8 hr Oregon R embryos were collected on apple juice plates, dechorionated and processed according to [@bib22], as per protocols 1 and 3 above, with the exception of using 37% formaldehyde stock from Sigma (cat. F1635-500ML). For [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, for non-AAGAG repeat RNAs, at least 50 cycle-14 embryos were imaged. With the exception of AAGAG(n) RNA, we did not quantify the percent of embryos with RNA foci. For [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, at least 10 embryos prior to cycle 12, at least three embryos for cycles 12 and 13, and hundreds of embryos for cycle 14 were imaged for AAGAG(n) foci.

Co-IF DNA/RNA-FISH of AAGAG RNA in embryos {#s4-5}
------------------------------------------

([Figure 1E](#fig1){ref-type="fig"}). Co-IF RNA/DNA-FISH was performed essentially as described in [@bib35], in which RNA-FISH was performed first, signal detected via tyramide signal amplification, RNAse treatment to remove RNA and prevent DNA-FISH probes binding to RNA, and then DNA-FISH performed. Essentially, RNA-FISH was performed as above, but after tyramide signal amplification (protocols 1 and 3 above) and washing, samples were fixed in 4% formaldehyde. Samples were then washed 3x in PBS 2 min. each. RNA was then removed under the following conditions: In a 50 μl final volume, 1X Shortcut RNaseIII buffer (NEB cat. M0245S), 1.5 ul RNASEIII (neb cat. MO245S), 100 μg/ml RNaseA final concentration, 1X MnCl2 (NEB cat. MO245S) and water to 50 μl were added and samples incubated overnight at 4°C. Samples were then rinsed 3x's in PBT 5 min each, rinsed in 1:5, 1:1 and 5:1 mixtures of PBT: RNA hybridization solution for 15 min each. Samples were then replaced with hybridization buffer and incubated 15 min. A DNA oligo probe to AAGAG(7) tagged with Alexa5 was then diluted in hybridization buffer to 2.5 ng/μl, denatured at 70°C for 3 min, then left on ice for 2 min. Hybridization solution was removed from the embryos, probe solution added, and the sample denatured at 80°C for 15 min and hybridized overnight at 37°C with nutation. Samples were then washed 2x's with pre-warmed 37°C hybridization buffer 10 min each. Samples were then washed in 3:1, 1:1, 1:3 hybridization buffer:PBT 15 min. each at 37°C. Samples were then washed 2x's in PBT at room temperature 5 min. each. Samples were then stained with DAPI 10 min., washed once in PBS, and mounted in Pro-Long Gold Antifade mountant.

RNA-FISH in larvae {#s4-6}
------------------

This protocol is essentially as described in [@bib15]. All figures containing larval RNA-FISH ([Figure 1B and D](#fig1){ref-type="fig"}, [Figure 2A and B](#fig2){ref-type="fig"} and [Figure 1---figure supplement 4, C--H](#fig1s4){ref-type="fig"}) used protocol A) and C) below. Those processed for TSA (needed for protocol three above) additionally used B below. For [Figure 1---figure supplement 6, A--C](#fig1s6){ref-type="fig"}, at least three brain lobes were imaged.

A.  Third instar larvae were dissected in PBS supplemented with 0.2 U/μl Protector RNase Inhibitor. The posterior end of the larvae was removed, then the remaining L3 inverted inside out. The inverted larvae were then transferred to ice cold PBS with 0.2 U/μl RNAse inhibitor. Larvae were then fixed in PBT with 4% formaldehyde for 15 min, then washed 3x, 5 min each with PBT. Larvae were then incubated with 0.1%(vol/vol) DEPC in PBT for 5 min to deactivate endogenous RNAses. Samples were then rinsed 2x's with PBS.

B.  Use of TSA amplification in L3 requires removal of endogenous peroxidases and requires the following protocol after DEPC treatment above and rinsing in PBS: In order to quench endogenous peroxidases, samples were incubated in 350 μl (enough to cover all tissue) of 3% H~2~O~2~ in PBS 15 min at room temperature and the tube kept open to prevent gas buildup. Samples were then rinsed 2x with PBT 10 min. each.

C.  To all larval samples: Larvae were then permeabilized by incubation in 500 μl cold 80% acetone in water at −20°C 10 min. Samples were then washed 2x, 5 min. per wash with PBT, then post fixed with 4% formaldehyde in PBT for 5 min. Samples were then washed 5x's with PBT 2 min each. Samples were then rinsed with 1:1 PBT/RNA hybridization solution, then with 100% RNA hybridization solution, and then stored in hybridization solution at −20°C until needed. Samples were then processed according to RNA-FISH protocol (protocol one above, under 'RNA FISH methods') for probe hybridization and either (protocol two above, under 'RNA FISH methods') for non-TSA probe or (protocol three above, under 'RNA FISH methods') for TSA amplification.

RNA-FISH in salivary gland squash {#s4-7}
---------------------------------

([Figure 1C](#fig1){ref-type="fig"}) Larvae were grown, prepped and salivary glands processed as per [@bib3], rehydrated in 95%, 70%, then 30% ethanol 1 min each, then washed 5 min in PBT (0.1% Triton X-100 (TX100)). Slides were then fixed again in 3.7% formaldehyde in PBT (0.1% TX100), washed 2x 3 min. each in PBT (0.1% TX100), treated with 0.1% DEPC in PBT (0.1% TX100) and washed one time in PBT (0.1% TX100). Sample was then covered with pre-denatured hybridization solution, covered with a coverslip and incubated at 56°C in a sealed hybridization chamber for 2 hr. The probe solution was then created by adding 100 ng probe in 100 μl hybridization solution, heating at 80°C for 3 min., and cooling on ice for 5 min. This probe solution was then added to the sample, a coverslip added and sealed with rubber cement, and incubated overnight at 56°C in a humid box. At 55°C in a coplin jar, slides were then treated in 50% formamide/PBT (0.1% tx100) 1 hr, 25% formamide/PBT (0.1% Tx100) 10 min, then 3x with PBT (0.1%Tx100) 10 min each. Once at room temp, samples were blocked in 1:1 PBT/2xWBR and processed as per larval RNA-FISH using non -TSA probe detection (protocol two above).

RNAse treatment of embryos {#s4-8}
--------------------------

([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}) For RNAse of embryos prior to probe hybridization: RNA-FISH to AAGAG was performed on embryos pre-treated with RNaseIII (which cleaves dsRNA; [@bib28]), RNaseH (which cleaves the RNA strand in RNA/DNA hybrids), RNase I (which non-specifically cleaves ssRNA and dsRNA), and RNaseA (which cleaves adjacent to pyrimidines, preferentially in ssRNA, and specifically not between purines such as 5'-AGAAGGGAGAAG \[[@bib10]; [@bib19]\]). Reaction conditions were as follows: Samples were treated in 50 μl final volume with either RNAseIII: 1X RNAseIII buffer, 1.5 μl Shortcut RNaseIII (New England Biolabs, cat. M0245s), and 1X MnCL~2~; RNAseH treatment: 1X RNAseH buffer, 1.5 μl RNAseH (New England Biolabs, cat. M0297S); RNAse one treatment: 1X RNAseH buffer, 1.5 μl RNAse1 (Ambion cat. AM2294); RNAse A treatment: 1x RNAseH buffer, 15 μg RNAseA- at 37°C for 5 hr. Samples were then washed 5x's in PBT 2 min each, treated with 0.1% DEPC to deactivate any remaining RNAse, then washed in PBT. Samples were then rinsed in 1:1 mixture of PBT:RNA hybridization solution for 2 min and resuspended in 100% hybridization solution. Samples were then processed as per 'RNA-FISH probe hybridization and primary antibody incubation' (protocol one above) and protocol 'TSA amplification for RNA-FISH probe detection' (protocol three above). For each condition, at least 10 entire embryos were imaged.

RNAse of embryos after probe hybridization {#s4-9}
------------------------------------------

([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}). After probe hybridization and washing with PBS, samples were treated in 50 μl final volume for either RNAseIII treatment: 1X RNAseIII buffer, 1.5 μl Shortcut RNaseIII (New England Biolabs, cat. M0245s), and 1X MnCL~2~ or RNAseH treatment: (1X RNAseH buffer, 1.5 μl RNAseH (New England Biolabs, cat. M0297S) at 37°C for 2 hr. Samples were then blocked with 2x PBT:WBR 1 hr then processed as per protocol 'TSA amplification for RNA-FISH probe detection' (protocol three above). Three embryos treated with RNaseH were imaged, while six treated with RNAseIII were imaged.

RNA-FISH in adult testes {#s4-10}
------------------------

For analysis of AAGAG RNA in RNAi adult testes ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}), flies were mated at 29°C and F~1~ progeny grown at 29°C to mimic conditions used to assess sperm morphological defects. AAGAG RNA was also visualized in RNAi testes grown at 25°C to rule out that temperature affected levels and distribution of AAGAG RNA (not shown). For analysis of AAGAG RNA in Oregon R and XO/XY testes ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), flies were grown at 25°C. Flies were then anesthetized with CO~2~, testes removed with forceps and placed in 7 μl of PBS on (+) charged slides, the contents spilled by poking with sharp forceps, a RainX-treated coverslip placed over the testes and both snap frozen in LiN~2~. The coverslip was then immediately removed with a razor blade and slides stored at −80°C until needed. When ready to process, slides were fixed for 20 min in 4% formaldehyde in PBT, washed three times, 5 min. each wash, in PBT. Samples were then incubated in 80% cold acetone in PBT for 10 min at −20°C and processed as per RNA-FISH for 'all larval samples' using protocol two above for detection without TSA amplification. For determination of average AAGAG(n) intensity levels, for each condition at least three testes were imaged, and at least 5 S5 spermatocytes derived from each of these testes were imaged.

Immuno-fluorescence in adult testes without RNA-FISH {#s4-11}
----------------------------------------------------

Flies were grown at 29°C and processed as above in 'RNA-FISH in adult testes' up until −80°C storage. Samples were then fixed 20 min in 4% formaldehyde in PBT, passed through an ethanol series (75--85--95%) at −20°C and dried prior to permeabilisation in 1X PBS-0.4% Triton X-100 (0.4 PBT). Samples were then blocked in 0.1PBT with 1% BSA for 1 hr at room temperature, incubated with primary antibodies overnight at 4°C and with secondary antibodies for 1 hr at room temperature (see [Table 3](#table3){ref-type="table"} for antibody information).

###### Antibodies used for Immuno-Fluorescence.

  Antibody                                     Supplier; Cat. number                       Working concentration
  -------------------------------------------- ------------------------------------------- -----------------------
  Rabbit-anti H3K9me3                          Abcam; 8898                                 1/250
  Mouse-anti H3K9me2                           Active Motif; 39753                         1/250
  Rabbit-anti-H2AV                             Lake placid AM318; 9751                     1/100
  Goat anti-GFP                                Rockland 121600-101-215                     1/500
  Rabbit anti-H4acetyl                         Millipore 06--598                           1/200
  Rat anti-Mst77F                              Elaine Dunleavy, PhD; NUI Galway, Ireland   1/200
  Guinea pig anti-Mst35Ba/Bb (Protamine A/B)   Elaine Dunleavy, PhD; NUI Galway, Ireland   1/200
  Mouse anti pan-histone                       Millipore MAB 3422                          1/200

Northern blotting {#s4-12}
-----------------

Non-radioactive, denaturing northern blots were essentially carried out according to Chemiluminescent Nucleic Acid Detection Module Kit (Thermofisher cat\# 89880). Essentially, purified RNA was denatured for 3 min at 70°C in NorthernMax formaldehyde loading dye. Samples were then run on denaturing agarose gels with 6.9% formaldehyde in MOPS buffer. RNA was transferred to (+) charged nylon membranes in an electroblotter (FisherBiotech Semi-Dry blotting unit, FB-SDB-2020) using 200mA for 30 min. The membrane was then UVC crosslinked and prehybridized with ULTRAhyb Ultrasensitive Hybridization Buffer (Thermofisher, cat\# 8669) at 68°C for 30 min. Biotinylated probes at a concentration of 30 ng/ml were then added to UltraHyb buffer, pre-hybridization solution replaced with solution containing probe and hybridized overnight at 68°C with rotation. The next day, membranes were washed and processed according to Chemiluminescent Nuclei Acid Detection kit manual. For Northern blots shown in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, at least three northern blots from three biological replicates were performed with similar patterns. For Northern blot shown in [Figure 1---figure supplement 6](#fig1s6){ref-type="fig"}, at least two biological replicates for each genotype were performed, with similar knockdown results.

Identification of genomic sources of AAGAG RNA {#s4-13}
----------------------------------------------

To identify the genomic origin of AAGAG RNA, we mined *D. melanogaster* transcriptome data (modENCODE staged embryo and L3 larvae total RNA-seq reads) ([@bib2]) for AAGAG RNA attached to mappable ends with uniquely mapped sequences and adjacent to \>50 bp blocks of annotated AAGAG(n) DNA. More specifically, we first used trim_galore to filter out adaptors and low quality sequencing reads. Reads with at least three consecutive AAGAG repeats were identified and their corresponding pair-end sequences were extracted. Including only AAGAG containing reads, assemble the other end sequences into contigs using Phrap (-vector_bound 0 -forcelevel 5 -minscore 30 -minmatch 10). We then used Blast (e-value \<10^−5^) to identify potential genomic locations in release 6 of *D. melanogaster* genome ([@bib12]) ([Table 4](#table4){ref-type="table"}). This conservative analysis revealed that the majority of AAGAG RNA originates from 2R and X heterochromatic satellites ([Table 4](#table4){ref-type="table"} and [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). To confirm that this computational genomic analysis identified sources of AAGAG transcripts, we performed northern blotting and RNA-FISH to these and a 3R heterochromatic region. Essentially, transcript sizes using probes to these regions are similar if not identical to AAGAG RNA, and foci from these mappable regions co-localize with AAGAG RNA foci ([Figure 1---figure supplement 4, B and C--H](#fig1s4){ref-type="fig"}, respectively), demonstrating that AAGAG RNA originates from identified 2R, X and 3R heterochromatin genomic regions.

###### Uniquely mapped RNA identified via phrap adjacent AAGAG(\>10) containing blocks

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Chr   e0-2hr                   e2-4hr   e4-8hr                   e8-12hr   e12-14hr                 e14-16hr                 e16-20hr                 e20-24hr
  ----- ------------------------ -------- ------------------------ --------- ------------------------ ------------------------ ------------------------ ------------------------
  2R    NA                       NA       NA                       NA        NA                       NA                       chr2R.1825640.1825699    NA

  X     NA                       NA       NA                       NA        NA                       NA                       NA                       chrX.12660077.12660134

  X     NA                       NA       NA                       NA        NA                       NA                       chrX.11830795.11830858   NA

  X     chrX.22453019.22453120   NA       chrX.22453019.22453182   NA        chrX.22453019.22453163   chrX.22453019.22453177   chrX.22453019.22453093   chrX.\
                                                                                                                                                        22453019.22453196
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Insertion of shRNA or overexpression constructs {#s4-14}
-----------------------------------------------

RNAi and overexpression lines were created via small-hairpin RNA (shRNA) to AAGAG RNA driven with the UAS/GAL4 system, or in the case of control, a scrambled RNA sequence, using genomic insertion of the pValium20 vector used for the Transgenic RNAi project (TRiP) at Harvard ([@bib27]). Importantly, the scrambled shRNA sequence contained the same percentage of A's and G's but in a random order (see [Table 5](#table5){ref-type="table"} for sequences). pValium20 constructs with shRNA or overexpression sequences (see next) were injected and screened for insertion by Rainbow Transgenic, Inc.

###### shRNA and overexpression oligos.

  Description                            Sequence 5'−3'
  -------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  shRNA to AAGAG(n)                      ctagcagtGAAGAGAAGAGAAGAGAAGAGtagttatattcaagcataCTCTTCTCTTCTCTTCTCTTCgcg
  shRNA to AAGAG(n) complement           aattcgcGAAGAGAAGAGAAGAGAAGAGtatgcttgaatataactaCTCTTCTCTTCTCTTCTCTTCactg
  shRNA to scrambled                     ctagcagtGAGAGAAAAAGGGAAAGAAGGtagttatattcaagcataCCTTCTTTCCCTTTTTCTCTCgcg
  shRNA to scrambled complement          aattcgcGAGAGAAAAAGGGAAAGAAGGtatgcttgaatataactaCCTTCTTTCCCTTTTTCTCTCactg
  AAGAG(37) for over-expression          ATCAAGACTGCTAGCAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAGAAGAG
  AAGAG(37) over-expression complement   CCATTGACTGAATTCCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTTCTCTT

Cloning of shRNA and over-expression constructs into pValium20 vector {#s4-15}
---------------------------------------------------------------------

Sense and antisense strands were annealed and ligated into digested pValium20 vector . For annealing, in a 50 μl final volume, 1.5 μl each of 100 μM stock oligos were added to 1X NEBuffer, incubated 4 min at 95°C, then slowly cooled to RT in a 1L beaker filled with 70°C water. Samples were blunt ended with klenow using standard procedures, purified with min-elute PCR purification kit, run on agarose gel, and appropriate size bands removed and purified. Purified bands were digested with Nhe1 and EcoR1 HF enzymes and purified with min-elute PCR purification kit. For cloning, 1 μl of annealed and purified oligo pair complement was added to 30 ng of digested pValium20 vector and ligated with T4 DNA ligase (not quick ligase) at 16°C overnight, and transformed into dh5alpha *E. coli* cells.

Viability assay {#s4-16}
---------------

y\[1\] v\[1\]:UAS-AAGAGshRNA:: (shRNA to AAGAG), y\[1\] v\[1\]:UAS-scramble shRNA:: (shRNA to scrambled) y\[1\] sc\[\*\] v\[1\]; P{y\[+t7.7\] v\[+t1.8\]=VALIUM20-mCherry}attP2 (dsRNA to mCherry) males were crossed to y\[1\] w\[\*\]:: P{w\[+mC\]=Act5 C-GAL4}17bFO1/TM6B, Tb\[1\] (actin-GAL4/Tubby) female virgins (see [Table 6](#table6){ref-type="table"} for fly lines). For calculation of ratios of RNAi/Tubby control prior to pupal stage ([Figure 1---figure supplement 6G](#fig1s6){ref-type="fig"}), the numbers of non-Tubby (RNAi) and Tubby pupae were scored. For each parental cross, a minimum of 11 biological replicates were completed at 25°C, and each vial included at least eight and no more than 43 pupae of any individual genotype. p-value (two tailed, type 3): \*\*p=0.013. For calculation of death rates during different stages of development, ([Figure 1---figure supplement 6H](#fig1s6){ref-type="fig"}), we used the following: To determine L1-L2 death rates, L1 and L2 Tubby and non-Tubby (RNAi) larvae were transferred to separate vials. Those that did not survive to visible L3 were scored as dead. To determine L3 death rates, L3 from lay plates were transferred to vials and those that did not survive to pupae were scored as dead. For pupal lethality, non-eclosed pupae from L1-L2, and L3 transfers were scored as dead. L1-L2 death rate (min. n L1/L2 analyzed per parental set of three experiments = 7 L1/L2): p-values (two tailed, type 3): A/M = AAGAG to mCherry; A/S = AAGAG to Scrambled; S/M = scrambled to mCherry; A/S = 0.457, A/M = 0.404; L3 death rate (min. n per five parental sets of L3 analyzed = 7 L3): A/S = 0.125, A/M = 0.019; Pupal death rate (min. n per three parental sets of pupae analyzed = 10 pupae): A/S = 0.002, A/M = 0.992, S/M = 0.002. Of note, the high pupal death in scrambled control is perplexing considering that we could not find mRNAs that would be targeted by this hairpin. We speculate that this lethality results from off-target effects on un-annotated RNA, and/or the hairpin RNA is toxic. Importantly, however, the lethal phase differed between AAGAG RNAi (L1-L3) vs scrambled RNAi (pupal) ([Figure 1---figure supplement 6H](#fig1s6){ref-type="fig"}).

###### Fly lines.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Stock name or genotype                                                                                                                                                                                                                                                                                                                                                                                                                               Obtained from: stock number                                                                         Description                                                                   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------- --
  y\[1\] v\[1\]; P{y\[+t7.7\]=CaryP}attP40                                                                                                                                                                                                                                                                                                                                                                                                             Bloomington: 36304                                                                                  Background strain for insertion of pValium20 vector containing shRNA          

  y\[1\] v\[1\]; P{y\[+t7.7\]=CaryP}attP2                                                                                                                                                                                                                                                                                                                                                                                                              Bloomington: 36303                                                                                  Background strain for\                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           insertion of pValium vector containing AAGAG expression construct.            

  y\[1\] sc\[\*\] v\[1\]; P{y\[+t7.7\] v\[+t1.8\]=VALIUM20-mCherry}attP2                                                                                                                                                                                                                                                                                                                                                                               Bloomington: 35785                                                                                  Control strain for RNAi. Expresses dsRNA to mCherry                           

  y\[1\] v\[1\]:UAS-AAGAG shRNA::                                                                                                                                                                                                                                                                                                                                                                                                                      Rainbow Transgenic Flies, Inc                                                                       Expresses shRNA under UAS promoter targeting AAGAG(n)                         

  y\[1\] v\[1\]:UAS-scramble shRNA::                                                                                                                                                                                                                                                                                                                                                                                                                   Rainbow Transgenic Flies, Inc                                                                       Expresses shRNA under UAS promoter targeting random AG containing sequences   

  y\[1\] w\[67c23\]; P{w\[+mC\]=dpp-GAL4.PS}6A/TM3, Ser\[1\]                                                                                                                                                                                                                                                                                                                                                                                           Bloomington: 7007                                                                                   Dpp-GAL4                                                                      

  y\[1\] v\[1\]::UAS-AAGAG(37)                                                                                                                                                                                                                                                                                                                                                                                                                         Rainbow Transgenic Flies, Inc                                                                       Expresses a 187 base repeat of AAGAG RNA under a UAS promoter                 

  [C(1](http://flybase.org/cgi-bin/fbidq.html?FBst0002494)[;Y)1, y\[1](http://flybase.org/cgi-bin/fbidq.html?FBst0002494)[\] w\[A738\]: y\[+\]/0 and](http://flybase.org/cgi-bin/fbidq.html?FBst0002494) [C(1](http://flybase.org/cgi-bin/fbidq.html?FBst0002494)[)RM, y\[1](http://flybase.org/cgi-bin/fbidq.html?FBst0002494)[\] v\[1](http://flybase.org/cgi-bin/fbidq.html?FBst0002494)[\]/0](http://flybase.org/cgi-bin/fbidq.html?FBst0002494)   Bloomington:2494                                                                                    XO (Y chromosome deficient males)                                             

  y\[\*\] w\[\*\]; P{w\[+mW.hs\]=GawB}NP1233/CyO,\                                                                                                                                                                                                                                                                                                                                                                                                     [Kyoto: 103948](https://kyotofly.kit.jp/cgi-bin/stocks/search_res_det.cgi?DB_NUM=1&DG_NUM=103948)   Fascillin-GAL4                                                                
  P{w\[-\]=UAS lacZ.UW14}UW14                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  y\[\*\] w\[\*\]; P{w\[+mW.hs\]=GawB}NP1624/CyO,\                                                                                                                                                                                                                                                                                                                                                                                                     [Kyoto:104055](https://kyotofly.kit.jp/cgi-bin/stocks/search_res_det.cgi?DB_NUM=1&DG_NUM=104055)    Traffic Jam-GAL4                                                              
  P{w\[-\]=UAS lacZ.UW14}UW14                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  w\[\*\]; P{w\[+mW.hs\]=GawB}ptc\[559.1\]                                                                                                                                                                                                                                                                                                                                                                                                             [Kyoto: 103948](https://kyotofly.kit.jp/cgi-bin/stocks/search_res_det.cgi?DB_NUM=1&DG_NUM=106629)   PTC-GAL4                                                                      

  :: nanos-Gal4, dcr2-UAS/TM3 sb                                                                                                                                                                                                                                                                                                                                                                                                                       Unknown                                                                                             Nanos-GAL4                                                                    

  w;;bamGAL4, UAS-dicer2                                                                                                                                                                                                                                                                                                                                                                                                                               Unknown                                                                                             Bam-GAL4                                                                      

  y\[1\] w\[\*\]::P{w\[+mC\]=Act5 C-GAL4}17bFO1/TM6B, Tb\[1\]                                                                                                                                                                                                                                                                                                                                                                                          Bloomington: stock 3954                                                                             Expresses GAL4 ubiquitously\                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           under control of Act5C promoter                                               
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fertility assay {#s4-17}
---------------

Flies containing shRNA to AAGAG or scrambled control were mated to different testes GAL4 drivers ([Table 1](#table1){ref-type="table"}) at 25°C, in at least duplicate parental (F~0~) sets. From each parental set, individual F~1~ male progeny (minimum of 12 per parental set) were then allowed to mate with two female Oregon R virgins for 10 days at 25°C. Male flies were counted as sterile if, after 10 days, the male and at least one female were still alive and no larvae, pupae or adult F~2~ progeny present. Female fertility was calculated as above, with one female RNAi and two Oregon R males. For Bam-GAL4-driven RNAi, female fertility was calculated as above from a minimum of three parental (F~0~) sets using a minimum of 10 F~1~ progeny for each. Scrambled RNAi male fertility for this cross was calculated as above from a minimum of four parental (F~0~) sets, using a minimum of 11 F~1~ progeny.

AAGAG Bam-GAL4-driven RNAi male fertility of 0% was calculated from \>\>10 (F~0~) parental sets, hundreds of F~1~ individual males, and at both 25°C and 29°C. For rescue experiments, triplicate parental sets were used, where one F~1~ male (minimum 15 per parental set) was mated to three Oregon R virgin females for 10 days and fertility assayed as above.

Morphology defects in RNAi sperm {#s4-18}
--------------------------------

For quantification of abnormalities in sperm DNA morphology ([Figure 3E](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), a minimum of 6 testes, each from a different male, were analyzed per genotype (see [Tables 7](#table7){ref-type="table"} and [8](#table8){ref-type="table"} below). Essentially, a projection image of the basal end of testes was made using a 40x confocal objective and all sperm DNA bundles were scored. See [Figure 3B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"} for examples of sperm DNA morphology. Calculations were based on the pooled percent of a given phenotype compared to total sperm bundles per genotype.

###### Quantification of post-canoe stage sperm DNA morphological defects in 4--7 day old testes.

  -----------------------------------------------------------------------------------------------------
                       N    Normal bundle   Lagging bundle   Kinked   Knotted   Needle\   Decondensed
                                                                                eyed      
  -------------------- ---- --------------- ---------------- -------- --------- --------- -------------
  Scrambled RNAi       1    2               2                4        0         0         0

                       2    9               7                6        0         0         0

                       3    21              5                0        0         0         0

                       4    5               1                0        0         0         0

                       5    29              1                0        0         0         0

                       6    6               2                0        0         0         0

  AAGAG RNAi           1    0               8                2        0         0         2

                       2    1               8                0        2         2         0

                       3    0               1                5        2         1         0

                       4    0               0                1        0         0         0

                       5    0               1                2        1         1         0

                       6    0               1                5        1         0         0

                       7    0               0                3        3         0         0

                       8    0               0                0        0         1         0

                       9    1               2                4        1         1         0

                       10   3               5                2        4         2         0

                       11   2               2                14       0         1         0

                       12   1               4                9        1         1         0

  AAGAG RNA (Rescue)   1    0               1                2        0         0         0

                       2    5               2                2        0         0         0

                       3    7               1                1        0         0         0

                       4    8               3                6        3         0         0

                       5    0               0                9        0         0         0

                       6    4               4                6        0         0         0

                       7    8               4                3        0         0         0

                       8    9               6                7        0         0         0

                       9    11              1                5        0         0         0

                       10   8               2                4        0         0         0

                       11   3               0                2        0         0         0

                       12   3               0                6        1         0         0

                       13   2               2                8        0         0         0

                       14   5               7                5        0         1         0

                       15   5               0                3        0         0         0

                       16   5               5                5        1         0         0

                       17   3               4                3        0         0         0

                       18   5               1                6        0         0         0

                       19   3               11               5        1         0         0

                       20   3               2                1        0         1         0
  -----------------------------------------------------------------------------------------------------

###### Quantification of canoe stage DNA morphological defects, in 4--7 day old testes

                       N    Normal canoe   Abnormal canoe
  -------------------- ---- -------------- ----------------
  Scrambled RNAi       1    2              0
                       2    7              1
                       3    6              1
                       4    3              5
                       5    9              1
                       6    5              1
  AAGAG RNAi           1    1              0
                       2    0              1
                       3    0              1
                       4    1              1
                       5    0              0
                       6    0              1
                       7    0              0
                       8    2              4
                       9    1              2
                       10   0              2
                       11   1              2
                       12   3              6
                       13   2              7
                       14   1              5
  AAGAG RNA (Rescue)   1    7              4
                       2    3              2
                       3    0              3
                       4    0              4
                       5    0              3
                       6    0              0
                       7    1              4
                       8    3              4
                       9    6              8
                       10   3              3
                       11   1              0
                       12   2              2
                       13   8              9
                       14   1              6
                       15   0              2
                       16   7              9
                       17   0              1
                       18   3              2
                       19   2              4
                       20   1              1

Cross to make XO males {#s4-19}
----------------------

For analysis of AAGAG RNA levels in male testes without a Y-chromosome, y\[1\]w\[1\] males were mated to C(1)RM, y\[1\] v\[1\]/0 females (Bloomington stock \# 2494) at 25°C and 0--6 hr testes from F~1~ males imaged.

qPCR conditions {#s4-20}
---------------

RNA was extracted and cDNA made by established methods. For qPCR, 10 μl 2X Absolute Blue qPCR SYBR low Rox mix (Thermofisher, cat. AB4318) was added, forward and reverse oligos each to 0.15 μM, 0.5 μl cDNA, and water to 20 μl. qPCR conditions were as follows: 95°C, 15 min; 40cycles (95°C 15 s, 58°C 30 s., 72°C 30 s); 72°C 30 s performed on AB 7500 Fast Real Time PCR System. Performed in biological triplicates. See [Table 9](#table9){ref-type="table"} for qPCR oligos.

###### qPCR oligos.

  mRNA target        Sequence 5'−3'
  ------------------ --------------------------
  Actin-5c Forward   CAGCCAGCAGTCGTCTAATC
  Actin-5c Reverse   ACAACCAGAGCAGCAACTTC
  Rpl32 Forward      CGATGTTGG GCATCAGATAC
  Rpl32 Reverse      CCCAAGATCGTGAAGAAGC
  pip5K59B Forward   CTCCTGCTCTGCTATCGTATTC
  pip5K59B Reverse   AGAGGAGCCATCAACATCAC
  Peb Forward        TGGTTGGACCGCTTAACATAG
  Peb Reverse        GCGACACCAAGAGCCATAA
  CG33080 Forward    ATTACGATCGCGGGCTTATC
  CG33080 Reverse    CGGTTCTAGGAGCACTGATATAAA
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

Transcription from repetitive DNA can nucleate heterochromatin formation, a structural role using RNA to decorate chromatin. Mills et al. show a surprising and focused requirement of a simple repeat RNA in development. This work shows that the AAGAG tandem repeat long noncoding RNA localizes in nuclear foci, primes *Drosophila* male germ line development, and is essential for male fertility. Although the mechanism of action is still unclear, these results highlight novel roles of nuclear noncoding RNA in chromatin organization and provided insights about in vivo functions that depends on lncRNA.

**Decision letter after peer review:**

Thank you for submitting your article \"RNA from a simple-tandem repeat is required for male fertility and histone-protamine exchange in *Drosophila melanogaster*\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by James Manley as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Yukiko M Yamashita (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Essential revisions:

The role of satellite RNA in spermatogenesis as presented in this study is extremely interesting, but there are major concerns, which must be addressed prior to publication.

1\) The authors use one short hairpin RNA (shRNA) construct to knockdown AAGAG RNAs and observe several phenotypes. To their credit, the authors show that the knockdown phenotype on fertility can be partially reversed by ectopic overexpression of the RNA. However, it was surprising that shRNA against mCherry also greatly reduces the AAGAG RNA (Figure 1---figure supplement 6). This raises concerns about the specificity of the experiment. Moreover, if the AAGAG RNA can be reduced but without phenotype in the mCherry shRNA experiments, then the concern is that the observed phenotypes are due to an off-target or non-specific effect of the particular shRNA. Independent RNAi lines or orthogonal methods to deplete or block AAGAG RNA are necessary to confirm the phenotype. Given that this study focuses on spermatogenesis, RNAi validation (AAGAG RNA-FISH) on AAGAG RNAi testes must also be shown.

2\) Whereas AAGAG RNAi phenotype is consistent with histone-protamine transition defects, many other upstream causes could lead to histone-protamine transition defects. Accordingly, the observed phenotype does not necessarily pinpoint AAGAG\'s function in histone-protamine exchange, and thus AAGAG RNA\'s function remains undefined. But the manuscript is written in a way to strongly indicate AAGAG is directly involved in a \'chromatin based\' mechanism that promotes histone-protamine exchange. We suggest that the authors be more cautious in writing (we are not asking to provide \'mechanism\' for AAGAG function in histone-protamine transition).

3\) The Northerns need clarification. The authors show that a 1.5-kb maternal product is loaded, and then RNA levels increase throughout development. There are several technical questions (e.g. the blots seem to cut off signal above 1.5-kb, how much of this RNA is coming from the satellite, where is the 1.5-kb signal coming from?). Regarding strands and satellite-derived RNA, it\'s not really clear what (+) and (--) mean. While it is ok to arbitrarily assign (+) and (--) with respect to the sequence \'AAGAG\', it would be surprising if the orientation within an AAGAG satellite block didn\'t occasionally flip. For example, a structural rearrangement of AAGAG tandem repeats could generate both types of transcripts (AAGAG and CUCUU) off of one strand. The presence of CUCUU in the spermatogenesis doesn\'t necessarily mean that the same repeats are transcribed off of both strands.
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Author response

> Essential revisions:
>
> The role of satellite RNA in spermatogenesis as presented in this study is extremely interesting, but there are major concerns, which must be addressed prior to publication.
>
> 1\) The authors use one short hairpin RNA (shRNA) construct to knockdown AAGAG RNAs and observe several phenotypes. To their credit, the authors show that the knockdown phenotype on fertility can be partially reversed by ectopic overexpression of the RNA. However, it was surprising that shRNA against mCherry also greatly reduces the AAGAG RNA (Figure 1---figure supplement 6). This raises concerns about the specificity of the experiment. Moreover, if the AAGAG RNA can be reduced but without phenotype in the mCherry shRNA experiments, then the concern is that the observed phenotypes are due to an off-target or non-specific effect of the particular shRNA. Independent RNAi lines or orthogonal methods to deplete or block AAGAG RNA are necessary to confirm the phenotype.

We are sorry the way we presented this data caused confusion about the specificity of RNAi. Although the AAGAG RNA signal in mCherry RNAi control lane appears weak, as stated in the legend "The AAGAG RNAi L3 AAGAG RNA top band signal is approximately 86% and 75% reduced compared to either scrambled or mCherry controls, respectively, when normalized to the actin-5c loading control." Thus, quantitation with proper normalization shows that AAGAG RNA is greatly reduced after AAGAG RNAi compared to either control (though there is a bit less depletion for mCherry vs. Scrambled). Yes, the Northern loading is not optimal, but producing a new Northern is greatly hampered by the departure of the lead and second authors from the lab.

More importantly, there are multiple lines of evidence supporting the specificity of the RNAi with respect to the observed phenotypes;

1\) The Northern results are validated by the AAGAG RNA-FISH (Figure 1---figure supplements 6A-D, in which we see abolishment of AAGAG RNA foci in L3 brain lobes with AAGAG RNAi but not in scrambled or mCherry controls. Additionally, we calculated the number of AAGAG RNA foci per nuclei with the sections we analyzed and find that when analyzing \>33 nuclei per section we see roughly 20% of mCherry nuclei per section have AAGAG RNA foci while 14% of scrambled RNAi have AAGAG RNA foci. Note that we analyzed the outermost sections of the brain for each genotype to eliminate artifacts from poor probe/antibody entry into deep tissue, and these numbers are only from confocal sections, and not from projections. This indicates that mCherry RNAi does not drastically affect AAGAG RNA foci compared to scrambled control, and both are distinct from the effects of AAGAG RNAi.

2\) The highly penetrant phenotypes are only observed after AAGAG RNAi, and not with either control.

3\) The phenotypes are partially (but significantly) rescued by addition of AAGAG RNA.

Thus, we believe that concerns about the phenotypes and off-target effects are not warranted. Note that we did try 'gapmers', but they did not knockdown AAGAG RNA and exhibited high toxicity after injection into syncytial embryos. We are not aware of other methods, including all current versions of CRISPR-Cas9, etc., that would, without significant development and optimization in flies, be useful for specific knockdown of this type of RNA without affecting underlying DNA or without producing unexpected phenotypes.

> Given that this study focuses on spermatogenesis, RNAi validation (AAGAG RNA-FISH) on AAGAG RNAi testes must also be shown.

RNAi validation of AAGAG RNAi knockdown of AAGAG in testes is shown in Figure 2---figure supplement 3.

> 2\) Whereas AAGAG RNAi phenotype is consistent with histone-protamine transition defects, many other upstream causes could lead to histone-protamine transition defects. Accordingly, the observed phenotype does not necessarily pinpoint AAGAG\'s function in histone-protamine exchange, and thus AAGAG RNA\'s function remains undefined. But the manuscript is written in a way to strongly indicate AAGAG is directly involved in a \'chromatin based\' mechanism that promotes histone-protamine exchange. We suggest that the authors be more cautious in writing (we are not asking to provide \'mechanism\' for AAGAG function in histone-protamine transition).

We agree that it is unclear if AAGAG functions directly in histone-protamine exchange and did not intend to strongly convey that conclusion. This is a striking phenotype, but there are many defects observed during sperm maturation. Further, direct effects (in a temporal sense) are unlikely given that all phenotypes are only visible when the RNA is *not* visible in wild-type, well after the primary spermatocyte stage. We have tried to alter the text to state that AAGAG RNA expression in primary spermatocytes is necessary for normal spermatogenesis, loss of AAGAG RNA causes the phenotypes, and direct vs. indirect effects cannot be distinguished.

That said, we have changed the title to emphasize effects on sperm maturation and fertility, rather than histone-protamine exchange.

We also included more information showing that AAGAG(37) RNA expression in primary spermatocytes partially rescues the sperm defects seen with AAGAG RNA depletion in primary spermatocytes. Specifically, we added new data to Figure 3E, confirming that rescue with AAGAG(37) RNA expression in primary spermatocytes in AAGAG RNAi background partially rescues individualization defects (only reported% fertile in previous version).

Additionally, we added a new figure, (Figure 3---figure supplement 1) showing that histones retained in AAGAG RNAi testes up to late canoe stage, but not in the control. This is an interesting finding considering that histones are generally removed just prior to late stage canoe and lends more support that AAGAG RNA affects histone:protamine transition (of course without addressing direct vs. indirect mechanism).

> 3\) The Northerns need clarification. The authors show that a 1.5-kb maternal product is loaded, and then RNA levels increase throughout development.

We do not claim that RNA levels increase throughout development, although it is likely given the increased signal in the Northerns throughout development. Similar levels of RNA were loaded per well (according to Qubit RNA high sensitivity measurements) and similar exposure times were used, but it is impossible to quantify levels between 0-24hr, larval vs. maternal and 2-4hr due to the absence of loading controls and separate northerns for later individual stages. We do not want to say anything at this time about the levels of RNA during development or in different tissues, so if any text suggests changes remains please point them out so we can remove them.

> There are several technical questions (e.g. the blots seem to cut off signal above 1.5-kb, how much of this RNA is coming from the satellite, where is the 1.5-kb signal coming from?).

Figure 1---figure supplement 2 Northern blots now have a larger cutoff and show that the 1,500 nt band is the largest band present. We speculate that this signal is coming from the AAGAG(n) regions adjacent chr3R:3,169,758-3,169,820, chr2R:1,826,691-1,826,740 and/or chrX:22,453,019-22,453,076 regions, as northern blotting to each of these regions produces a 1,500 nt band (Figure 1---figure supplement 4B). It is unclear why they all present as a 1,500 nt band, although it is possible they originate in different sizes and are processed to 1,500 nt or smaller.

> Regarding strands and satellite-derived RNA, it\'s not really clear what (+) and (--) mean. While it is ok to arbitrarily assign (+) and (--) with respect to the sequence \'AAGAG\', it would be surprising if the orientation within an AAGAG satellite block didn\'t occasionally flip. For example, a structural rearrangement of AAGAG tandem repeats could generate both types of transcripts (AAGAG and CUCUU) off of one strand.

We agree that there could be 'flipping' and other structural changes, and we struggled with how to present this complex experiment and data. We intend to use the (+) and (--) only in reference to the probes and annotated DNA sequence, not putative adjacent sequences that may have 'flipped' or changed. Figure 1---figure supplement 4A has been changed to provide more clarification and indicate where the probes will bind when designated (+) and (-). Text has also been changed to indicate that orientation of an AAGAG satellite block may occasionally flip (though note it is striking that in embryos we cannot find the complementary RNA foci...if flipping occurred we'd expect to see some).

> The presence of CUCUU in the spermatogenesis doesn\'t necessarily mean that the same repeats are transcribed off of both strands.

We agree, and did not intend to state they are transcribed off both strands. Again, we want to know if specific text remains that suggests this is the case.
